Discussion about this post

User's avatar
Just steve's avatar

What does it take to break free from the Yes, It Does This One Thing, Look no further, There Is No Need to Look Further - time to toss it out there and see if it then does break, injures, causes something worse...meh...more business, profit opportunities. What does take to break free from wait until someone is sick and then address symptoms, not the cause or causes.

What does it take to stop the attacks on those who pursue True, Real Health to build Health, to Prevent Dis-Ease in the first place, to if possible actually repair, restore as much Real Health as possible and then if stuck with treat the symptoms for relief as a lost resort.

Real Health supports other forms of Real Wealth, Foundational Wealth beyond material Profit$, Profit$, Profits, short term gains for shareholders. Real Health and Real Wealths' potential is to make the Material Wealth actually have more meaning. Just Sayn'

Guillermou's avatar

Hundreds of people in the UK have suffered pancreatic problems linked to the use of weight-loss injections such as Ozempic, Wegovy, and Mounjaro. These cases have prompted health authorities to launch an investigation into the side effects of GLP-1 drugs (glucagon-like peptide-1 receptor agonists).

According to the British newspaper The Guardian, the increase in cases of pancreatitis associated with the use of these medications was detected through the Medicines and Healthcare products Regulatory Agency's (MHRA) Yellow Card Scheme.

Pancreatitis is one of the rare adverse reactions listed in the package inserts for these drugs. Theoretically, UK health authorities have detected nearly 400 cases in patients who used Mounjaro, Wegovy, Ozempic, and liraglutide.

Of these, almost half (181) were linked to tirzepatide (Mounjaro), the British newspaper reports. More than a quarter of these cases were reported in 2025. "Along with increased use, we are seeing a rise in the number of Yellow Card reports mentioning GLP-1 drugs and acute pancreatitis," an MHRA spokesperson told The Guardian. The Medicines and Healthcare products Regulatory Agency has announced it will launch a study to investigate the causes of these adverse effects. "This needs to be thoroughly examined." Dr. Alison Cave, director of safety at the MHRA, stated: "Evidence shows that almost a third of drug side effects could be prevented with the introduction of genetic testing. Adverse drug reactions are projected to cost the NHS more than £2.2 billion a year in hospitalizations alone."

https://www.theguardian.com/society/2025/jun/26/weight-loss-diabetes-jab-users-report-pancreas-problems (25/05/26)

1 more comment...

No posts

Ready for more?